$PDCO (Patterson Companies, Inc.)

$PDCO {{ '2015-07-08T20:56:14+0000' | timeago}} • SEC

$PDCO FY15 10-K: On June 16, 2015, PDCO completed the previously announced acquisition of Animal Health International, Inc. Under terms of definitive agreement, PDCO has acquired all of Animal Health International’s stock for $1.1Bil in cash. Animal Health International generated sales of $1.5Bil & EBITDA of $68MM during 12 months ended March 2015.

$PDCO {{ '2017-11-21T17:10:59+0000' | timeago}} • Announcement

When announcing 2Q18 results, $PDCO cut down its previously announced FY18 outlook. Patterson now expects GAAP EPS to be $1.67-1.77 compared with the previous outlook of $1.90-2.05. Non-GAAP EPS expectation was also trimmed to $2.00-2.10 band from the earlier range of $2.25-2.40.

$PDCO {{ '2017-11-21T17:09:44+0000' | timeago}} • Announcement

$PDCO said that its 2Q18 profit was impacted by the strategic actions taken by the company, market conditions and the impact of hurricanes. Net income dropped 12% to $40MM or $0.43 per share, while sales slipped 2.3% to $1.4Bil. Adjusted earnings slide 9% to $0.51 per share.

$PDCO {{ '2017-11-21T15:31:11+0000' | timeago}} • Infographic

$PDCO Patterson Companies, Inc. Earnings AlphaGraphic: Q2 2018 Highlights

$PDCO {{ '2017-09-19T21:59:10+0000' | timeago}} • Announcement

$PDCO's BoD declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, Oct. 27, 2017, to shareholders of record as of the close of business on Oct. 13, 2017.

$PDCO {{ '2017-08-24T13:05:12+0000' | timeago}} • Announcement

$PDCO reaffirmed its FY18 guidance and expects the GAAP earnings to be in the range of $1.90 to $2.05 per diluted share. The non-GAAP earnings would be in the range of $2.25 to $2.40 per diluted share. In 1Q18, it repurchased approx. 0.8MM shares of its outstanding common stock, with a value of $37.5MM.

$PDCO {{ '2017-08-24T12:59:27+0000' | timeago}} • Announcement

The dental wing of $PDCO, which comprises 40% of the total sales, suffered as its net sales nosedived by 6.5% to $518.8MM in 1Q18. The company expects that a broadened portfolio in the dental segment would help overcome the lean patch. The Animal Health division fared better with a net sales of $776.1MM, 1.8% higher than same period last year.

$PDCO {{ '2017-08-24T12:57:20+0000' | timeago}} • Announcement

Lower sales and higher rates of depreciation and amortization pulled back the net income of $PDCO, a medical supplies firm, to $30.8MM or $0.33 per diluted share in 1Q18 compared to $38.9MM, or $0.40 per diluted share last year. The net sales dipped by 2.1% to $1.30Bil from $1.33Bil a year ago.

$PDCO {{ '2017-08-24T10:53:06+0000' | timeago}} • Announcement

Patterson Dental, a business unit of $PDCO, and $ALGN announced a distribution agreement for $ALGN's iTero Element intraoral scanning system. This agreement expands Patterson's portfolio of CAD/CAM products with iTero scanner's proven digital technology and superior Invisalign experience and tools.

$PDCO {{ '2017-06-21T21:19:20+0000' | timeago}} • Announcement

$PDCO has named Kevin Pohlman as Interim President of Patterson Animal Health, effective July 1. He will succeed John Adent, current CEO of Patterson Animal Health, who is leaving to pursue other opportunities. Mr. Pohlman will report directly to Interim President and CEO, Jim Wiltz.

$PDCO {{ '2017-06-13T20:38:09+0000' | timeago}} • Announcement

The BoD of $PDCO declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, July 28, 2017, to shareholders of record as of the close of business on July 14, 2017.

$PDCO {{ '2017-06-07T17:38:29+0000' | timeago}} • Announcement

$PDCO said it has been added to the Fortune 500 list of America's largest companies, based on revenues, for the first time since its inception 140 years ago. In fiscal 2017, Patterson Companies recorded net sales of $5.6Bil, a 3.8% growth from 2016.

$PDCO {{ '2017-06-01T12:49:34+0000' | timeago}} • Announcement

CEO of $PDCO and Chairman of its Board, Scott Anderson, will step down from those roles, effective immediately. James Wiltz, a director of the company, will assume the role of interim CEO. John Buck, currently the Lead Director, will assume the role of non-executive Chairman. A search is on to find a permanent CEO.

$PDCO {{ '2017-05-25T15:08:06+0000' | timeago}} • Webcast

On working capital, $PDCO commented that in total it came down in 4Q17, but was still up YoY by about $60MM. The company believes it has additional opportunities to improve its working capital levels over the next year.

$PDCO {{ '2017-05-25T14:46:02+0000' | timeago}} • Webcast

For FY17, $PDCO generated cash flow from operations of $166MM, down from $195MM in FY16. Over the next five years, the company continues to expect to generate more than $1.3Bil of free cash flow. CapEx for FY17 totaled $47MM and expects FY18 CapEx to be in the range of about $50MM.

$PDCO {{ '2017-05-25T14:40:04+0000' | timeago}} • Webcast

$PDCO said that in its Animal Health business reported sales grew 6% YoY in 4Q17. The company expects ERP expenses to continue into FY18 at an annual level of about $30MM. $PDCO expects a step up in expenses to occur in 1H18, with a proportionate step down in the cost in 2H18.

$PDCO {{ '2017-05-25T11:43:37+0000' | timeago}} • Announcement

$PDCO expects FY18 EPS of $1.90-2.05 and non-GAAP EPS of $2.25-2.40. The non-GAAP earnings forecast excludes after-tax impact of deal amortization expense, integration and business restructuring expenses, and transaction-related costs. The forecast assumes North American and international market conditions similar to FY17.

$PDCO {{ '2017-05-25T11:41:23+0000' | timeago}} • Announcement

$PDCO reported a decline in 4Q17 earnings due to lower sales. Net income fell to $61.69MM or $0.65 per share from $65.62MM or $0.68 per share last year. Net sales declined to $1.445Bil from $1.454MM. Non-GAAP EPS decreased to $0.69 from $0.77.

$XRAY {{ '2017-05-09T11:11:53+0000' | timeago}} • Announcement

$XRAY announced a new distribution agreement with $PDCO, continuing its partnership over many years. Additionally, $XRAY announced a new three-year agreement with $HSIC, effective September 1, 2017 to distribute $XRAY's full line of dental equipment in the US.

$PDCO {{ '2017-05-01T21:45:15+0000' | timeago}} • Announcement

$PDCO said Alex Blanco, EVP and Chief Supply Chain Officer at Ecolab, was elected to its BoD, increasing the board's size to nine members. Blanco will serve on the board's audit committee and will also be on the governance and nominating committee.

$PDCO {{ '2017-03-15T11:37:37+0000' | timeago}} • Announcement

$PDCO increased its quarterly dividend to $0.26 per share, up 8% from the prior quarter. The dividend, which improves the annual cash dividend to $1.04 per share, will be payable on or about April 28, 2017, to shareholders of record at business close on April 14, 2017.

Recent Transcripts

UNH (UnitedHealth Group Incorporated)
Tuesday, January 16 2018 - 1:45pm
ENZ (Enzo Biochem Inc.)
Friday, December 8 2017 - 1:30pm
PDCO (Patterson Companies, Inc.)
Tuesday, November 21 2017 - 3:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
CCXI (ChemoCentryx, Inc.)
Tuesday, November 7 2017 - 10:00pm
CAH (Cardinal Health, Inc.)
Monday, November 6 2017 - 1:30pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
MOH (Molina Healthcare, Inc.)
Thursday, November 2 2017 - 9:00pm
PLUS (ePlus inc.)
Thursday, November 2 2017 - 8:30pm
ARW (Arrow Electronics, Inc.)
Thursday, November 2 2017 - 5:00pm
HSKA (Heska Corporation)
Thursday, November 2 2017 - 3:00pm
ABC (AmerisourceBergen Corporation)
Thursday, November 2 2017 - 12:30pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
IDXX (IDEXX Laboratories, Inc.)
Tuesday, October 31 2017 - 12:30pm

AlphaGraphics you may like